sever
acut
respiratori
syndrom
sar
sever
form
pneumonia
transmiss
pattern
high
mortal
rate
possibl
reemerg
futur
make
sar
seriou
threat
neither
effici
therapi
vaccin
current
avail
diseas
caus
member
coronaviru
famili
sar
coronaviru
sarscov
fouchier
et
al
follow
viral
entri
cell
two
polyprotein
name
molecular
weight
kda
respect
synthes
rota
et
al
viral
life
cycl
process
put
nonstructur
protein
two
viral
proteas
papainlik
proteas
main
proteinas
mpro
also
name
proteas
review
ziebuhr
et
al
sarscov
mpro
respons
cleavag
site
replicas
polyprotein
snijder
et
al
releas
viral
enzym
need
replic
rnadepend
rna
polymeras
helicas
well
accessori
protein
nonstructur
protein
function
fulli
understood
thu
given
pivot
role
viral
life
cycl
mpro
attract
target
develop
drug
direct
sar
viru
threedimension
structur
mpro
enzym
report
sever
coronavirus
includ
human
cov
anand
et
al
porcin
transmiss
gastroenter
viru
tgev
anand
et
al
sarscov
yang
et
al
studi
use
escherichia
coli
overexpress
system
purifi
sarscov
mpro
obtain
novel
crystal
form
ph
diffract
high
resolut
contain
one
monom
per
asymmetr
unit
activesit
residu
oxyanion
hole
adopt
function
conform
indic
crystal
form
might
use
structurebas
drug
design
dna
fragment
encod
sarscov
mpro
strain
sin
ruan
et
al
amplifi
pcr
use
pfu
polymeras
stratagen
clone
new
england
biolab
incorpor
maltosebind
protein
mbp
nterminu
sarscov
mpro
forward
primer
contain
xmni
site
bold
revers
primer
contain
bamhi
site
bold
downstream
stop
codon
taa
four
addit
amino
acid
iegr
introduc
facilit
remov
mbp
factor
xa
transform
e
coli
cell
grown
k
lb
media
supplement
glucos
attain
iptg
ad
final
concentr
mm
temperatur
lower
k
h
cell
harvest
centrifug
min
resuspend
buffer
mm
ph
mm
nacl
mm
edta
lyse
sonic
min
follow
centrifug
min
k
supernat
load
onto
econocolumn
biorad
pack
amylos
resin
new
england
biolab
equilibr
buffer
incub
overnight
k
fusion
protein
elut
k
use
mm
ph
mm
nacl
mm
edta
mm
maltos
load
onto
hiprep
q
sepharos
ff
column
amersham
equilibr
buffer
b
mm
ph
mm
nacl
mm
edta
protein
elut
use
linear
nacl
concentr
gradient
buffer
c
mm
ph
nacl
mm
edta
fraction
contain
mbpsarscov
mpro
pool
concentr
ultrafiltr
centricon
vivasci
desalt
mm
ph
mm
nacl
mm
use
column
amersham
one
unit
factor
xa
ad
per
fusion
protein
h
k
cleavag
factor
xa
remov
use
resin
qiagen
cleav
product
load
onto
xk
phenyl
sepharos
resin
column
amersham
equilibr
buffer
mm
ph
mm
nacl
mm
dtt
mm
edta
recombin
sarscov
mpro
elut
use
buffer
e
mm
ph
mm
dtt
mm
edta
fraction
contain
sarscov
mpro
pool
buffer
chang
mm
ph
mm
edta
mm
dtt
concentr
mg
determin
use
bradford
method
biorad
bsa
standard
store
k
crystal
sarscov
mpro
grown
use
hangingdrop
vapourdiffus
method
equal
volum
protein
mother
liquor
mix
well
contain
me
ph
k
macroseed
produc
thin
elong
platelik
crystal
period
one
week
data
collect
crystal
soak
cryoprotect
solut
contain
glycerol
me
ph
mount
cool
k
nitrogenga
stream
oxford
cryosystem
diffract
intens
record
beamlin
european
synchrotron
radiat
facil
grenobl
franc
adsc
ccd
detector
use
attenu
beam
mm
integr
scale
merg
intens
carri
use
program
suit
collabor
comput
project
number
datacollect
refin
statist
present
tabl
structur
sarscov
mpro
readili
solv
molecular
replac
use
program
amor
suit
sarscov
mpro
structur
deposit
pdb
code
search
model
program
use
refin
cycl
altern
rebuild
session
use
program
jone
et
al
reflect
set
asid
monitor
progress
refin
use
r
free
factor
water
molecul
ad
automat
use
arpwarp
perraki
et
al
check
visual
inspect
qualiti
model
assess
use
procheck
laskowski
et
al
structur
superposit
perform
lsqkab
collabor
comput
project
number
model
compris
one
monom
per
asymmetr
unit
residu
five
residu
cterminu
visibl
electrondens
map
omit
residu
domain
domain
ii
form
chymotrypsinlik
structur
observ
sever
viral
proteas
includ
picornavirus
togavirus
flavivirus
babe
craik
ctermin
domain
residu
sarscov
mpro
requir
activ
sinc
truncat
fragment
compris
catalyt
domain
display
signific
decreas
enzymat
activ
bacha
et
al
structur
function
studi
coronaviru
mpro
shown
dimer
requir
maxim
proteas
activ
respect
promin
role
play
seven
aminotermin
amino
acid
adopt
extend
conform
make
extens
contact
domain
ii
monom
ensur
format
catalyt
compet
activ
site
yang
et
al
crystal
form
activ
dimer
gener
crystallograph
twofold
contact
establish
mobil
shown
higher
averag
temperatur
factor
path
main
chain
howev
close
follow
observ
previous
report
activ
monom
rm
deviat
equival
mainchain
atom
pdb
code
chain
yang
et
al
fig
latter
crystal
form
belong
space
group
contain
one
dimer
asymmetr
unit
quasitwofold
symmetri
indic
ntermin
residu
absolut
requir
activ
site
adopt
activ
conform
figur
show
distribut
thermal
factor
sarscov
main
proteinas
avail
supplementari
substratebind
site
locat
cleft
two
catalyt
dyad
cystein
thiol
act
nucleophil
use
instead
classic
serhisasp
triad
serin
proteas
fig
b
although
crystal
obtain
ph
valu
presum
near
pk
valu
residu
substratebind
site
enzym
show
slightli
reduc
activ
conform
activ
site
indic
activ
enzym
fig
b
immedi
vicin
activ
site
involv
extens
intermolecular
contact
neighbour
molecul
thu
crystal
form
like
suitabl
studi
involv
soak
cocrystal
small
compound
rather
long
peptid
interestingli
cours
prepar
submiss
manuscript
relat
crystal
form
sarscov
mpro
report
hsu
et
al
tan
et
al
